Robert E. Gerszten, MD

Robert E. Gerszten, MD, is Chief of Cardiovascular Medicine at Beth Israel Deaconess Medical Center, the Herman Dana Professor of Medicine at Harvard Medical School, and a Senior Associate Member of the Broad Institute. His research focuses on the nexus of cardiac and metabolic diseases. This translational research program is a national leader in the use of metabolomics and proteomic technologies and the integration of this information with human genetics for the discovery of new biomarkers and pathways contributing to atherogenesis and its complications. The Gerszten team has identified novel biomarkers that single out individuals destined to develop diabetes and heart disease more than a decade before disease onset, with the goal of determining which of these patients might benefit from clinical interventions. Dr. Gerszten’s research is funded by the National Institutes of Health and the American Heart Association. He is an active clinician in the Coronary Care Unit. 

Dr. Gerszten received his medical degree from Johns Hopkins University School of Medicine. After completing his residency in internal medicine at the Hospital of the University of Pennsylvania, he performed a cardiovascular research fellowship at the Cardiovascular Research Institute at the University of California, San Francisco, followed by additional research and clinical training at  at Massachusetts General Hospital.

Education and Training

• Johns Hopkins School of Medicine

• Residency, University of Pennsylvania

• Clinical Fellowship, Cardiology at Massachusetts General Hospital

• Research Fellowship, Cardiovascular Research Institute, University of California, San Francisco

• Research Fellowship, Cardiovascular Research Center, Massachusetts General Hospital